MicroRNA Market Size, Share Global Analysis Report, 2023 – 2030

Industry Insights

[180+ Pages Report] According to the report published by Facts Factors, the global microRNA market size was worth around USD 1,240 million in 2022 and is predicted to grow to around USD 3,960 million by 2030 with a compound annual growth rate (CAGR) of roughly 18.04% between 2023 and 2030. The report analyzes the global microRNA market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the microRNA market.

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the MicroRNA industry. The report analyzes and declares the historical and current trends analysis of the MicroRNA industry and subsequently recommends the projected trends anticipated to be observed in the MicroRNA market during the upcoming years.

The MicroRNA market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entireMicroRNA market. The historical and past insights are provided for FY 2020 to FY 2022 whereas projected trends are delivered for FY 2023 to FY 2030. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2020 – 2030.

Key Insights from Primary Research

• As per our analysis, the MicroRNA market is set to grow annually at a rate of around 18.04%
• It was valued through primaryresearch that the MicroRNAmarket was valued at around USD 1,240 Million in 2022
• North Americais currently holding the largestshare among all the regions and expected to continue the trend in the upcoming period.
• Rapid progress is expected to foster Asia Pacific growth in genomic studies and increasing use of advanced technologies.

Key Recommendations from Analysts

• As per our analysisit was anticipated that during the forecast period application of the market will grow majorly in developed countries
• The market value for year 2030 was estimated USD 3,960 Million
• Asia-Pacific region is likely to witness fastest growth during the analysis period
• As per our analysts, recent innovations and increasing applications are expected to contribute over the forecast period to market growth forMicroRNA.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the MicroRNA industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the MicroRNA industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the MicroRNA market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the MicroRNA industry. The MicroRNA market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the MicroRNAsector. Key strategic developments in the MicroRNA market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the MicroRNA market are appropriately highlighted in the report.

The move from platform technology to applications is expected to fuel the market. The development of drugs and biologics across virtual drug development systems provides significant advantages over traditional models, such as reducing risk and overhead costs in combination with conventional technologies. MirNAs play a significant role in various biological processes, such as time-control development, cell proliferation, apoptosis, stem cell maintenance, differentiation, signal pathways, and pathogenesis, such as carcinogenesis. During the forecast period, this factor is expected to increase the market growth.

The MicroRNA market research report delivers an acutevaluationand taxonomy of the MicroRNA industry by practically splitting the market on the basis of different applications, end-use, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026.

Report Scope

The regional segmentation of the MicroRNA industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the MicroRNA industry is provided for the leading economies of the world.

The MicroRNA market is segmented based on application and end-use. On the basis of application segmentation, the market is classified into clinical diagnostics and research. In terms of end-use segmentation, the market is bifurcated into research and academic institutes, contract research organizations, biopharmaceutical companies, and diagnostic centers.

Some of the major players operating in the MicroRNA market

• Affymetrix
•  Alnylam Pharmaceuticals Inc.
• AstraZeneca Pharmaceuticals LP
•  Santaris Pharma
•  Biogen Idec Inc.
•  Exiqon
•  Pfizer Inc.
•  CBC Biomarker Center GmbH
•  Eli Lilly and Co.
•  F. Hoffman-La Roche
•  GlaxoSmithKline
•  Novartis AG and Merck & Co.

The taxonomy of the MicroRNA industry by its scope and segmentation is as follows:

By ApplicationSegmentation Analysis

• Clinical Diagnostics
• Research

By End-Use Segmentation Analysis

• Research and Academic Institutes
• Contract Research Organizations
• Biopharmaceutical Companies
• Diagnostic Centres

By Regional Segmentation Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa